Section

Technology & Innovation

Digital therapeutics, AI in recovery, telehealth, startup moves.

Telehealth Is Selling GLP-1s for Addiction Before the FDA Has Said Whether They Work

Weight-loss shots are being prescribed for alcohol and other addictions through online clinics. The evidence is early, and the checkout page is not a trial.

Online addiction clinics are prescribing GLP-1 drugs off-label for alcohol use disorder ahead of FDA approval. What the early trial data show and what to ask before you start.

Oct 233 minRead

More in Technology & Innovation

39 total in this section

02Technology & InnovationOct 21

Overdose Deaths Are Down 12%, and the CDC Just Built a Dashboard to Prove It. Good. Now Fix What It Can't See.

CDC's new Overdose Prevention Data Channel reports 67,798 predicted deaths in the 12 months to March 2026, down 12.3%. What the number says and what it hides.

03Technology & InnovationSep 29

A Breakthrough Badge Isn't a Treatment. Meth Patients Need the One That Already Works.

NET Recovery's device got FDA Breakthrough designation for stimulant use disorder on Sept. 23. What that does and doesn't mean, and what clinics can offer today.

04Technology & InnovationSep 28

Arizona Built an AI Front Door for Opioid Treatment. It Inherited the Same Broken Directory.

AHCCCS, Google Public Sector, and Syntasa launched a generative-AI opioid treatment locator for Arizona. The federal locator it's meant to improve on has a documented history of stale data and dead ends — the question is whether a chatbot fixes that or just says it faster.

05Technology & Innovation

Earlier in Technology & Innovation

Every piece in this section, most recent first.

Technology & Innovation

Telehealth Is Selling GLP-1s for Addiction Before the FDA Has Said Whether They Work

More in Technology & Innovation

Overdose Deaths Are Down 12%, and the CDC Just Built a Dashboard to Prove It. Good. Now Fix What It Can't See.

A Breakthrough Badge Isn't a Treatment. Meth Patients Need the One That Already Works.

Arizona Built an AI Front Door for Opioid Treatment. It Inherited the Same Broken Directory.

No Drug Treats Stimulant Addiction Yet. The FDA Just Fast-Tracked a Device That Might.

The Best Treatment for Meth and Opioids Is a Gift Card. Silicon Valley Would Rather Sell You a Watch.

Washington Keeps Rescuing Telehealth Bupe at the Last Minute. That's Not a Policy.

Earlier in Technology & Innovation

Virtual MOUD Platforms Sell Access. New Data Says They're Selling a Detour.

The Government Calls Telehealth Prescribing Permanent. The Rule Expires in 113 Days.

Arizona's New AI Treatment Locator Can Answer 'Where.' It Still Can't Answer 'Is There a Bed.'

AI Just Caught Addiction Coalitions Stigmatizing Their Own Best Medicine

Arizona Built a Chatbot to Solve the Problem Rize Was Founded to Solve

Brave Died. The Tech It Proved Didn't.

A Patch That Doses Naloxone for 24 Hours Solves a Real Problem — Years From Now

A Patch That Doesn't Wait for Someone to Notice You're Overdosing

An Addiction Clinic Just Built an AI Companion App for Everyone

A Wearable Patch Just Beat Usual Care at Breaking the Craving-to-Use Pipeline

Your Phone Can Already Predict Your Next Cigarette. Nobody's Built the App That Uses It.

Digital Health Raised $7.4 Billion in Six Months. A New Report Says Virtual Addiction Care Still Isn't Solving the Real Problem.

A Gambling Addiction Startup Just Did What No Fentanyl App Ever Managed: Get a State to Pay For It

Eli Lilly Just Paid $3.8 Billion to Bet That Depression's Next Blockbuster Looks Like DMT

Lilly's $3.8B Psychedelic Bet Skips Past the People Who Need It Most

Digital Health Just Raised $7.4 Billion. Addiction Treatment Barely Shows Up in the Count.

Arizona's Medicaid Agency Built an AI Chatbot to Find You Opioid Treatment. Will You Trust It at 2 A.M.?

Six Months In, Compass Pathways' Psilocybin Data Clears the Bar Lykos Couldn't

The Addiction-Tech Money Isn't Drying Up. It's Just Betting Almost Entirely on AI Now.

South Carolina Put a Naloxone Machine in a Public Building. The Data It Collects Might Matter More Than the Doses.

Three Different Clocks Are Running Out on Mail-Order Ketamine, and Only One of Them Is About Safety

Psilocybin Is Closer to FDA Approval Than Most People in Treatment Know. Here's the Timeline.

Relationship between attentional bias and psychological craving in methamphetamine use disorder

An AI Can Now Diagnose Addiction With 83% Accuracy. The Treatment System Still Can't Keep Up.

Ozempic for Addiction? The Science Is Catching Up to the Headlines

Virtual MOUD Doesn't Expand Access. That's Not a Failure — It's the Map.

The State of Digital Recovery Funding in 2026: Quiet Year, Selective Bets

Bicycle Health Doubles Down on Clinical Leadership — Days After PHTI Calls Virtual MOUD a Substitute, Not a Door

Smartphone-delivered contingency management is being studied. The economics already make sense.

NIH HEAL is still the biggest addiction-tech grant pool no one applies for

Pelago, Boulder, Workit, Ophelia — Who's Who in Digital Recovery

The State of Recovery Technology in 2026